FDA — authorised 29 September 2017
- Application: BLA208751
- Marketing authorisation holder: NOVO
- Local brand name: FIASP
- Indication: SOLUTION — INTRAVENOUS, SUBCUTANEOUS
- Status: approved
🇺🇸 Insulin Faster Aspart in United States
FDA authorised Insulin Faster Aspart on 29 September 2017
Marketing authorisation
Other Diabetes approved in United States
Frequently asked questions
Is Insulin Faster Aspart approved in United States?
Yes. FDA authorised it on 29 September 2017.
Who is the marketing authorisation holder for Insulin Faster Aspart in United States?
NOVO holds the US marketing authorisation.